PHILADELPHIA—(Dec. 4, 2023) — Dario C. Altieri, M.D. — The Wistar Institute’s president and CEO, director of its Ellen and Ronald Caplan Cancer Center and the Robert & Penny Fox Distinguished Pro…
PHILADELPHIA—(Nov. 1, 2023)— The Wistar Institute’s David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center (VIC) and W.W. Smith Charitable Trust Distingu…
PHILADELPHIA (October 17, 2023) – The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious diseases, announces the appointment of Dean Stoios as Chief Financi…
Dario C. Altieri, M.D., president and chief executive officer of The Wistar Institute will be honored by the Justinian Foundation and Society of Philadelphia for exemplifying the finest qualities of…
PHILADELPHIA—(Sep. 18, 2023)—Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has publ…
PHILADELPHIA—(Sept. 7, 2023)—The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, is pleased to announce the recruitment of Avi Srivastava…
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased to announce the recruitment of Jesper Pallesen, MBA, Ph.D., as assistant pr…
PHILADELPHIA—(August 22, 2023)—Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the j…
PHILADELPHIA—(August 9, 2023)— The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, is pleased to announce the appointment of Alexander Pri…
Philadelphia – (August 8, 2023) – The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Joy Taylor to its Board…
